Course: Targeted Therapy for NSCLC: Antibody-Drug Conjugates (ADCs)
CME Credits: 1.00
Released: 2025-02-28
This video series provides an overview of the adoption of antibody-drug conjugates (ADCs) to treat non-small cell lung cancer (NSCLC). The series will cover:
Upon completion of this activity, participants should be better able to:
View Full Course